返回 Agenda
Session 7B: Leveraging the Patient Voice, Site/Investigator, and Digital Health Technologies: How Can We Transform the Healthcare Landscape More Effectively?
Session Chair(s)
Nan Shao, PhD
Executive Vice President, Global Operations
Veristat, United States
Digital health technologies are transforming the healthcare industry at large. With clinical research quickly adopting the decentralized clinical trial approach in light of the pandemic, the use of patient sensors, wearables, mobile apps, etc., is becoming common in drug development as opposed to the traditional patient data collection primarily through electronic data capture (EDC). This session will explore how digital health technology aids drug development and the complications it brings in consideration of the patient’s experience, investigator's view, technology innovator and data scientist's perspectives, etc.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify the industry trend of digital health technology
- Discuss the use cases of digital health technologies in clinical research
- Discuss challenges in adopting digital health technologies and exchange ideas for further advancement in this space
Speaker(s)
Speaker
Ella Balasa
United States
Patient Advocate and Engagement Consultant
Speaker
Bertrand Sohier
Parexel International, France
Senior Vice President, Global Medical Services
Speaker
Ali Neishabouri, PhD
Actigraph, United States
Head of Data Science